Literature DB >> 3132534

Slow penetration of thyrotropin-releasing hormone across the blood-brain barrier of an in situ perfused guinea pig brain.

B V Zloković1, M N Lipovac, D J Begley, H Davson, L Rakić.   

Abstract

Transport of 3H-labelled thyrotropin-releasing hormone (TRH) across the blood-brain barrier was studied in the ipsilateral perfused in situ guinea pig forebrain. The unidirectional transfer constant (Kin) calculated from the multiple time brain uptake analysis ranged from 1.14 X 10(-3) to 1.22 X 10(-3) ml min-1 g-1, in the parietal cortex, caudate nucleus, and hippocampus. Regional Kin values for [3H]TRH were significantly reduced by 43-48% in the presence of an aminopeptidase and amidase inhibitor, 2 mM bacitracin, suggesting an enzymatic degradation of tripeptide during interaction with the blood-brain barrier. In the presence of unlabelled 1 mM TRH and 2 mM bacitracin together, a reduction of [3H]TRH regional Kin values similar to that obtained with 2 mM bacitracin alone was obtained . L-Prolinamide, the N-terminal residue of tripeptide, at a 10 mM level had no effect on the kinetics of entry of [3H]TRH into the brain. The data indicate an absence of a specific saturable transport mechanism for TRH presented to the luminal side of the blood-brain barrier. It is concluded that intact TRH molecule may slowly penetrate the blood-brain barrier, the rate of transfer being some three times higher than that of D-mannitol.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3132534     DOI: 10.1111/j.1471-4159.1988.tb04864.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  10 in total

1.  Insulin detemir is not transported across the blood-brain barrier.

Authors:  William A Banks; John E Morley; Jessica L Lynch; Kristin M Lynch; Arshag D Mooradian
Journal:  Peptides       Date:  2010-09-22       Impact factor: 3.750

Review 2.  Small molecular drug transfer across the blood-brain barrier via carrier-mediated transport systems.

Authors:  Akira Tsuji
Journal:  NeuroRx       Date:  2005-01

Review 3.  Delivering peptides to the central nervous system: dilemmas and strategies.

Authors:  W A Banks; A J Kastin; C M Barrera
Journal:  Pharm Res       Date:  1991-11       Impact factor: 4.200

Review 4.  Peptides at the blood brain barrier: Knowing me knowing you.

Authors:  Thomas P Davis; Thomas J Abbruscato; Richard D Egleton
Journal:  Peptides       Date:  2015-04-30       Impact factor: 3.750

Review 5.  Cerebrovascular permeability to peptides: manipulations of transport systems at the blood-brain barrier.

Authors:  B V Zlokovic
Journal:  Pharm Res       Date:  1995-10       Impact factor: 4.200

6.  The possible role of glutamate uptake in metaphit-induced seizures.

Authors:  M N Lipovac; T Holland; A Poleksic; C Killian; A Lajtha
Journal:  Neurochem Res       Date:  2003-05       Impact factor: 3.996

7.  Effects of triglycerides, obesity, and starvation on ghrelin transport across the blood-brain barrier.

Authors:  William A Banks; Basil O Burney; Sandra M Robinson
Journal:  Peptides       Date:  2008-07-17       Impact factor: 3.750

8.  Minimal penetration of lipopolysaccharide across the murine blood-brain barrier.

Authors:  William A Banks; Sandra M Robinson
Journal:  Brain Behav Immun       Date:  2009-09-06       Impact factor: 7.217

9.  Design and exploratory neuropharmacological evaluation of novel thyrotropin-releasing hormone analogs and their brain-targeting bioprecursor prodrugs.

Authors:  Katalin Prokai-Tatrai; Vien Nguyen; Szabolcs Szarka; Krisztina Konya; Laszlo Prokai
Journal:  Pharmaceutics       Date:  2013       Impact factor: 6.321

10.  Neurovascular damage in experimental allergic encephalomyelitis: a target for pharmacological control.

Authors:  C Bolton
Journal:  Mediators Inflamm       Date:  1997       Impact factor: 4.711

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.